| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
33,511,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile MiNK Therapeutics is a clinical stage biopharmaceutical company engaged in the discovery, development and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Co.'s key product candidate, AGENT-797, is an off-the-shelf, allogeneic iNKT cell therapy. In addition, Co. is developing a pipeline of allogeneic iNKT programs. Co.'s key programs include a CAR-iNKT program targeting B-cell maturation antigen (BCMA), which it refers to as BCMA-CAR-iNKT, and a tumor stromal targeting CAR-iNKT program, which it refers to as stromal target-CAR-iNKT. These programs are both in preclinical development.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
646,494 |
666,494 |
| Total Buy Value |
$0 |
$0 |
$789,827 |
$817,474 |
| Total People Bought |
0 |
0 |
2 |
3 |
| Total Buy Transactions |
0 |
0 |
13 |
15 |
| Total Shares Sold |
0 |
0 |
100,000 |
100,000 |
| Total Sell Value |
$0 |
$0 |
$94,850 |
$94,850 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
1 |
1 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wiinberg Ulf |
|
– • – |
2024-03-01 |
4 |
A |
$0.95 |
$15,001 |
D/D |
15,790 |
90,333 |
|
- |
|
| Behner Peter |
|
– • – |
2024-03-01 |
4 |
A |
$0.95 |
$15,376 |
D/D |
16,185 |
75,027 |
|
- |
|
| Corvese Brian |
|
– • – |
2024-03-01 |
4 |
A |
$0.95 |
$17,875 |
D/D |
18,816 |
365,527 |
|
- |
|
| Ryan Barbara |
|
– • – |
2024-03-01 |
4 |
A |
$0.95 |
$17,751 |
D/D |
18,685 |
86,617 |
|
- |
|
| Behner Peter |
|
– • – |
2023-12-01 |
4 |
A |
$1.04 |
$15,375 |
D/D |
14,784 |
58,842 |
|
- |
|
| Wiinberg Ulf |
|
– • – |
2023-12-01 |
4 |
A |
$1.04 |
$15,001 |
D/D |
14,424 |
74,543 |
|
- |
|
| Corvese Brian |
|
– • – |
2023-12-01 |
4 |
A |
$1.04 |
$17,876 |
D/D |
17,188 |
346,711 |
|
- |
|
| Ryan Barbara |
|
– • – |
2023-12-01 |
4 |
A |
$1.04 |
$17,751 |
D/D |
17,068 |
67,932 |
|
- |
|
| Agenus Inc |
|
– – • |
2023-10-16 |
4 |
B |
$1.10 |
$472 |
D/D |
429 |
21,772,863 |
0.01 |
- |
|
| Agenus Inc |
|
– – • |
2023-10-13 |
4 |
B |
$1.10 |
$21,310 |
D/D |
19,373 |
21,772,434 |
0.01 |
- |
|
| Agenus Inc |
|
– – • |
2023-10-12 |
4 |
B |
$1.10 |
$3,488 |
D/D |
3,173 |
21,753,061 |
0.01 |
- |
|
| Buell Jennifer |
Chief Executive Officer |
• • – |
2023-10-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(695,750) |
232,165 |
|
- |
|
| Agenus Inc |
|
– – • |
2023-10-04 |
4 |
B |
$1.09 |
$16,380 |
D/D |
15,001 |
21,749,888 |
0.01 |
- |
|
| Buell Jennifer |
Chief Executive Officer |
• • – |
2023-10-03 |
4 |
D |
$0.94 |
$61,419 |
D/D |
(65,000) |
927,915 |
|
- |
|
| Buell Jennifer |
Chief Executive Officer |
• • – |
2023-10-02 |
4 |
D |
$1.04 |
$61,155 |
D/D |
(58,550) |
992,915 |
|
- |
|
| Buell Jennifer |
Chief Executive Officer |
• • – |
2023-09-29 |
4 |
D |
$1.15 |
$28,845 |
D/D |
(25,000) |
1,051,465 |
|
- |
|
| Buell Jennifer |
Chief Executive Officer |
• – – |
2023-09-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
695,750 |
1,076,465 |
|
- |
|
| Baldoni John |
|
– • – |
2023-09-01 |
4 |
A |
$1.46 |
$14,375 |
D/D |
9,846 |
41,193 |
|
- |
|
| Ryan Barbara |
|
– • – |
2023-09-01 |
4 |
A |
$1.46 |
$17,751 |
D/D |
12,158 |
50,864 |
|
- |
|
| Corvese Brian |
|
– • – |
2023-09-01 |
4 |
A |
$1.46 |
$17,876 |
D/D |
12,244 |
329,523 |
|
- |
|
| Wiinberg Ulf |
|
– • – |
2023-09-01 |
4 |
A |
$1.46 |
$14,001 |
D/D |
9,590 |
60,119 |
|
- |
|
| Behner Peter |
|
– • – |
2023-09-01 |
4 |
A |
$1.46 |
$15,375 |
D/D |
10,531 |
44,058 |
|
- |
|
| Agenus Inc |
|
– – • |
2023-08-29 |
4 |
B |
$1.52 |
$45,016 |
D/D |
29,678 |
21,734,887 |
0.01 |
- |
|
| Agenus Inc |
10% Owner |
– – • |
2023-08-28 |
4 |
B |
$1.45 |
$18,570 |
D/D |
12,808 |
21,705,209 |
2.37 |
- |
|
| Agenus Inc |
10% Owner |
– – • |
2023-08-24 |
4 |
B |
$1.54 |
$262,908 |
D/D |
170,244 |
21,692,401 |
2.45 |
- |
|
67 Records found
|
|
Page 1 of 3 |
|
|
